uniQure N.V. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
uniQure N.V. (QURE) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.52 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-05
- uniQure N.V. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.52M shares, a 13.22% increase year-over-year.
- uniQure N.V. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 7.55M shares, a 0.39% decline year-over-year.
- uniQure N.V. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 7.76M shares, a 8.32% decline year-over-year.
- uniQure N.V. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 7.53M shares, a 13.87% decline year-over-year.
- uniQure N.V. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 7.49M shares, a 10.52% increase from fiscal 2024.
- uniQure N.V. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.78M shares, a 9.21% decline from fiscal 2023.
- uniQure N.V. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.46M shares, a 15.58% increase from fiscal 2022.
- uniQure N.V. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.46M shares, a 69.31% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | 8.52M shares 10-Q · filed 2026-05-05 | ||||
| 2025-12-31 | 7.49M shares 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | 7.55M shares 10-Q · filed 2025-11-10 | 7.55M shares 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | 7.76M shares 10-Q · filed 2025-07-29 | 7.76M shares 10-Q · filed 2025-07-29 | |||
| 2025-03-31 | 7.53M shares 10-Q · filed 2026-05-05 | ||||
| 2024-12-31 | 6.78M shares 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | 7.58M shares 10-Q · filed 2025-11-10 | 7.58M shares 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | 8.47M shares 10-Q · filed 2025-07-29 | 8.47M shares 10-Q · filed 2025-07-29 | |||
| 2024-03-31 | 8.74M shares 10-Q · filed 2025-05-09 | ||||
| 2023-12-31 | 7.46M shares 10-K · filed 2026-03-02 | ||||
| 2023-09-30 | 8.16M shares 10-Q · filed 2024-11-05 | 8.16M shares 10-Q · filed 2024-11-05 | |||
| 2023-06-30 | 8.03M shares 10-Q · filed 2024-08-01 | 8.03M shares 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | 7.92M shares 10-Q · filed 2024-05-07 | ||||
| 2022-12-31 | 6.46M shares 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | 6.61M shares 10-Q · filed 2023-11-07 | 6.61M shares 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | 6.87M shares 10-Q · filed 2023-08-01 | 6.87M shares 10-Q · filed 2023-08-01 | |||
| 2022-03-31 | 6.43M shares 10-Q · filed 2023-05-09 | ||||
| 2021-12-31 | 3.81M shares 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | 4.20M shares 10-Q · filed 2022-11-02 | 3.31M shares 10-Q · filed 2022-11-02 | |||
| 2021-06-30 | 3.39M shares 10-Q · filed 2022-08-08 | 3.36M shares 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | 4.14M shares 10-Q · filed 2022-05-02 | ||||
| 2020-12-31 | 3.35M shares 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | 11.71M shares 10-Q · filed 2021-10-25 | 11.71M shares 10-Q · filed 2021-10-25 | |||
| 2020-06-30 | 11.60M shares 10-Q · filed 2021-07-26 | 11.60M shares 10-Q · filed 2021-07-26 | 11.60M shares 10-Q · filed 2020-07-30 | ||
| 2020-03-31 | 13.92M shares 10-Q · filed 2021-05-10 | ||||
| 2019-12-31 | 12.44M shares 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | 12.63M shares 10-Q · filed 2020-10-27 | ||||
| 2019-06-30 | 12.24M shares 10-Q · filed 2020-07-30 | ||||
| 2019-03-31 | 12.68M shares 10-Q · filed 2020-04-29 | ||||
| 2018-12-31 | 12.11M shares 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | 11.20M shares 10-Q · filed 2019-10-28 | ||||
| 2018-06-30 | 11.24M shares 10-Q · filed 2019-07-29 | ||||
| 2018-03-31 | 11.03M shares 10-Q · filed 2019-04-29 | ||||
| 2017-12-31 | 10.56M shares 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | 9.07M shares 10-Q · filed 2018-11-06 | ||||
| 2017-06-30 | 8.89M shares 10-Q · filed 2018-08-08 | ||||
| 2017-03-31 | 7.20M shares 10-Q · filed 2018-04-30 | ||||
| 2016-12-31 | 6.53M shares 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | 6.82M shares 10-Q · filed 2017-11-01 | ||||
| 2016-06-30 | 7.28M shares 10-Q · filed 2017-08-08 | ||||
| 2016-03-31 | 7.21M shares 10-Q · filed 2017-05-09 | ||||
| 2015-12-31 | 6.98M shares 10-K · filed 2018-03-14 | ||||
| 2014-12-31 | 3.27M shares 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |